ClinicalTrials.Veeva

Menu

Organ Retractor Device Study

Boehringer Ingelheim logo

Boehringer Ingelheim

Status

Enrolling

Conditions

Liver Retraction During Bariatric Surgery

Treatments

Device: liver retraction

Study type

Observational

Funder types

Industry

Identifiers

NCT06754514
Retractor-01

Details and patient eligibility

About

This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • undergoing minimally invasive primary bariatric surgery

Exclusion criteria

  • known liver disease

Trial contacts and locations

1

Loading...

Central trial contact

Business Development

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems